Amprion, Inc.
SAN FRANCISCO, CA · CIK 0001937140 · Medtech · Private
Protein misfolding cyclic amplification (PMCA) platform for detecting tau oligomers in blood for Alzheimer's disease diagnosis
amprion.ai →- Grants
- $6.3M
- 9 awards
- Sector median: 1
- Raised
- $15M
- 2 Form D · Sep 2024
- 24 months since last filing
- Contracts
- $2.2M
- 2 awards · Health and Human S
- #212 of 4531 in medtech
- Patents
- 40
- 9 granted · 31 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201420162018202020222024
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase II · Blood-based diagnostics for Alzheimer's Disease | $223,574 | |
| Federal grant | Department of Health and Human Services · Phase II · Blood-based diagnostics for Alzheimer's Disease | $509,989 | |
| Federal grant | Department of Health and Human Services · Phase II · Blood based diagnostics for Alzheimer s Disease | $1,069,735 | |
| Federal grant | Department of Health and Human Services · Phase II · Blood-based diagnostics for Alzheimer's Disease | $64,680 | |
| Federal grant | Department of Health and Human Services · Phase II · Development of a Biochemical Diagnosis for Creutzfeldt Jakob disease | $2,468,398 | |
| Federal grant | Department of Health and Human Services · Phase II · Blood-based diagnostics for Alzheimer's Disease | $495,066 | |
| Federal grant | Department of Health and Human Services · Phase II · Highly selective detection of tau oligomers in biological fluids for the diagnosis of Alzheimer's Disease | $217,647 | |
| Federal grant | Department of Health and Human Services · Phase II · Highly selective detection of tau oligomers in biological fluids for the diagnosis of Alzheimer's Disease | $663,017 | |
| Federal grant | Department of Health and Human Services · Phase II · Highly selective detection of tau oligomers in biological fluids for the diagnosis of Alzheimer's Disease | $618,037 | |
| Private capital raised | Form D · SEC | $10,956,960 | |
| Federal contract | Department of Health and Human Services · Protein Analysis In Cerebrospinal Fluid Samples | $1,064,800 | |
| Federal contract | Department of Health and Human Services · Protein Analysis In Cerebrospinal Fluid Samples | $1,126,400 | |
| Private capital raised | Form D · SEC | $3,761,381 |
Federal grant · SBIR/STTRFederal contract · USAspendingForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 209 | Oculogica Inc. | $2.2M | $22M |
| 210 | SAFETRACES, INC | $2.2M | $19M |
| 211 | INNOVATIVE SURFACE TECHNOLOGIES INC | $2.2M | — |
| 212 | Amprion, Inc. | $2.2M | $15M |
| 213 | NeuroPace | $2.2M | $187M |
| 214 | DREAM SYSTEMS, LLC | $2.2M | — |
| 215 | X-Therma Inc. | $2.2M | $35M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Rahul BhansaliDirector
- Marc ChanDirector
- Peter ClintonDirector
- Russell LebovitzDirector · Executive Officer
- Kenneth LehmanDirector
- Claudio SotoDirector
Patents
- Detection of Misfolded Alpha Synuclein Proteingranted
- Discriminating Parkinson's Disease from Multiple System Atrophy Using Alpha-Synuclein PMCAapplication
- Inert Matrices For Qualitative And Semi-quantitative Seed Amplification Assaysapplication
- Discriminating Parkinson's Disease From Multiple System Atrophy Using Alpha-synuclein Pmcagranted
- Inert Matrices For Qualitative And Semi-quantitative Seed Amplification Assaysgranted
- Alpha Synuclein Substrates And Methods For Making And Using The Sameapplication
- Detection Of Misfolded Alpha Synuclein Proteinapplication
- Alpha-synuclein Detection Using Beadsapplication
- Alpha-synuclein Substrates And Methods For Making And Using The Samegranted
- Alpha-synuclein Detection Using Beadsgranted
- Alpha-synuclein Seed Amplification Assay For Peripheral Matricesapplication
- Alpha-synuclein Substrates And Methods For Making And Using The Samegranted
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.